According to Alpine Immune Sciences's latest financial reports the company's current revenue (TTM) is £43.06 M. In 2023 the company made a revenue of £46.21 M an increase over the revenue in the year 2022 that were of £24.85 M.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.